Pubblicazioni

Alpha-1 adrenergic antagonists, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction. A systematic review and meta-analysis of urodynamic studies

2018 - NEUROUROLOGY AND URODYNAMICS

Fusco, F.; Creta, M.; De Nunzio, C.; Gacci, M.; Li Marzi, V.; Finazzi Agro, E.

Benign prostatic enlargement can be influenced by metabolic profile. results of a multicenter prospective study

2017 - BMC UROLOGY

Gacci, Mauro; Sebastianelli, Arcangelo; Salvi, Matteo; De Nunzio, Cosimo; Vignozzi, Linda; Corona, Giovanni; Jaeger, Tommaso; Chini, Tommaso; Russo, Giorgio Ivan; Maggi, Mario; Morgia, Giuseppe; Tubaro, Andrea; Carini, Marco; Serni, Sergio

Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: A critical analysis of five phase III studies

2017 - THERAPEUTIC ADVANCES IN UROLOGY

Tubaro, Andrea; Batista, JosÃ© E.; Nitti, Victor W.; Herschorn, Sender; Chapple, Christopher R.; Blauwet, Mary Beth; Siddiqui, Emad; Huang, Moses; Oelke, Matthias

Detrusor overactivity increases bladder wall thickness in male patients: a urodynamic multicenter cohort study

2016 - NEUROUROLOGY AND URODYNAMICS

DE NUNZIO, Cosimo; Presicce, Fabrizio; Lombardo, Riccardo; Carter, Simon; Vicentini, Carlo; Tubaro, Andrea

The diagnosis of benign prostatic obstruction: validation of the young academic urologist clinical nomogram

2015 - UROLOGY

De Nunzio, Cosimo; Lombardo, Riccardo; Gacci, Mauro; Milanesi, Martina; Cancrini, Fabiana; Tema, Giorgia; Cocci, Andrea; Giordano, Giovanni; Leonardo, Costantino; Carini, Marco; Tubaro, Andrea